CN1981837B - Chinese-medicinal composition for adjusting human-body viscera function - Google Patents
Chinese-medicinal composition for adjusting human-body viscera function Download PDFInfo
- Publication number
- CN1981837B CN1981837B CN200510107272A CN200510107272A CN1981837B CN 1981837 B CN1981837 B CN 1981837B CN 200510107272 A CN200510107272 A CN 200510107272A CN 200510107272 A CN200510107272 A CN 200510107272A CN 1981837 B CN1981837 B CN 1981837B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- rhizoma
- chinese medicine
- fructus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese medicine for regulating the functions of human viscera is proportionally prepared from 23 Chinese-medicinal materials including red sage root, cinnamon twig, peach kernel, scutellaria root, etc.
Description
Technical field
The invention belongs to the medicinal preparation technical field, particularly a kind of pure Chinese medicinal preparation of adjusting human-body viscera function.
Background technology
Along with the quickening of modern's rhythm of life, the quantity of sub-health population also increases thereupon, and the sickness rate of fatigue syndrome chronic diseases disease is soaring year by year especially.Mainly treat both at home and abroad in recent years, but curative effect is difficult to long-term consolidation with the Western medicine verification, and with untoward reaction.And use the research of this type of disease of Chinese medicine method diagnosis and treatment to obtain significant curative effect at present.Though motherland's medical science think people's spirit and consciousness and thinking activities have the inclination lead, also closely related with the catharsis function of liver.Liver can not store blood, then the heart do not have lead, the operation of blood must cause not normal.QI movement being in harmonious way, QI and blood and accent could improve the organism fatigue state, form to coordinate and unified integral body, reach the purpose for the treatment of both the principal and secondary aspects of a disease.
Summary of the invention
The object of the invention is to provide a kind of Chinese medicine composition of adjusting human-body viscera function.
For reaching above-mentioned purpose, the present invention adopts following technical scheme: a kind of Chinese medicine composition of adjusting human-body viscera function is mainly formed by following parts by weight of traditional Chinese medicines preparation of raw material:
Rhizoma Polygoni Cuspidati 210-270 part, fry Fructus Toosendan 84-108 part, Fructus Schisandrae Chinensis 70-90 part, Radix Scrophulariae 210-270 part, Radix Salviae Miltiorrhizae 140-180 part, Ramulus Cinnamomi 70-90 part, Semen Persicae 70-90 part, Radix Scutellariae 63-81 part, Radix Et Rhizoma Rhei 70-90 part, Semen Arecae 84-108 part, Rhizoma Bolbostematis 105-135 part, Cortex Moutan 84-108 part, Flos Carthami 35-45 part, Carapax et Plastrum Testudinis 70-90 part, Scorpio 70-90 part, Radix Glycyrrhizae 70-90 part, Carapax Trionycis 70-90 part, Poria 70-90 part, Concha Ostreae 140-180 part, Herba Hedyotidis Diffusae 140-180 part, Radix Bupleuri 70-90 part, Rhizoma Coptidis 21-27 part, Fructus Aurantii 70-90 part.
The raw material of Chinese medicine parts by weight are: 270 parts of Rhizoma Polygoni Cuspidati, 108 parts of Fructus Toosendans of stir-fry, 90 parts of Fructus Schisandrae Chinensis, 270 parts of Radix Scrophulariaes, 180 parts of Radix Salviae Miltiorrhizaes, 90 parts of Ramulus Cinnamomi, 90 parts in Semen Persicae, 81 parts of Radix Scutellariaes, 90 parts of Radix Et Rhizoma Rhei, 108 parts of Semen Arecaes, 135 parts of Rhizoma Bolbostematiss, 108 parts of Cortex Moutans, 45 parts on Flos Carthami, 90 parts of Carapax et Plastrum Testudiniss, 90 parts of Scorpios, 90 parts in Radix Glycyrrhizae, 90 parts of Carapax Trionycis, 90 parts in Poria, 180 parts of Concha Ostreae, 180 parts of Herba Hedyotidis Diffusaes, 90 parts of Radix Bupleuri, 27 parts of Rhizoma Coptidis, 90 parts of Fructus Aurantiis.
Also contain and be prepared into the required excipient of common drug preparation.
It is any pharmaceutics dosage form.
The present invention can adopt following prepared: take by weighing primary medicine by weight ratio, remove impurity, dry post-treatment becomes fine powder, sterilization packaging.Through ripening, capsule is gone in sterilization, gets capsule.
The present invention emphasizes liver master blood, main catharsis, department's muscle arteries and veins, has one's ideas straightened out in order according to Chinese medicine determining the pathogenesis of ZANG-FU disease based on the differentiation of symptoms and signs theory; And Liver Channel is around in external genitals, on meet at the important evidence on the crown.Based on depressed liver-energy dispersing and QI regulating, nourishing YIN and benefiting blood, easing the affected liver hepatoprotective, select the natural Chinese medicines compatibility with reference to modern medicine study for use,, concoct respectively, combine in conjunction with modern advanced technologies method for making through the strictness screening by the theory of Chinese medical science prescription.
The invention belongs to mediation side, be intended to recover function of human body and delay the internal organs organ failure. regulate the flow of vital energy Rhizoma Polygoni Cuspidati, Radix Scutellariae, Radix Scrophulariae, Rhizoma Coptidis, Radix Et Rhizoma Rhei, Herba Hedyotidis Diffusae dampness removing with Radix Bupleuri, stir-fry Fructus Toosendan, Fructus Aurantii, Semen Arecae; Radix Salviae Miltiorrhizae, Scorpio, Rhizoma Bolbostematis eliminating stagnation; Cortex Moutan, Semen Persicae, Flos Carthami blood circulation promoting and blood stasis dispelling; The Fructus Schisandrae Chinensis nourishing kidney of astringing the lung; Carapax et Plastrum Testudinis, Carapax Trionycis, Concha Ostreae suppressing the hyperactive liver and subsiding YANG; Poria, Radix Glycyrrhizae invigorating the spleen and replenishing QI coordinating the actions of various ingredients in a prescription be drug effect altogether.
Indication of the present invention comprises: diseases such as gallbladder silt calculus, fatty liver, gastrointestinal dysfunction, chronic pancreatitis, sexual disorder, nipple discharge, distending pain of the breast, dysmenorrhea, dysarteriotony, insomnia, bradycardia, female climacteric syndrome.Instructions of taking is: oral former medicine 4-5 gram/time, twice of every day.
Chinese medicine composition observation on Clinical Application of the present invention is summarized as follows:
1, case is selected: select (1) Patients with Fatty Liver 10 examples, (2) nipple discharge patient 10 examples, (3) insomniac 15 examples, gastrointestinal dysfunction patient 15 examples.
2, treatment standard:
Clinical recovery: symptom complete obiteration, function of human body recover normal, and the clinical examination index is normal.
Produce effects: cardinal symptom disappears, and the function of human body base can recover substantially, and clinical examination is normal substantially.
Effectively: cardinal symptom disappears substantially, and main function of human body and clinical examination index make moderate progress.
Invalid: with the treatment before compare, each side does not all have improvement.
3, clinical statistics:
(1) 10 routine Patients with Fatty Liver clinical practices observation of the present invention is shown that the present invention has obvious curative effects to fatty liver.Be the moderate fatty liver by B ultrasonic and CT demonstration before the treatment, triglyceride, cholesterol raise, often with symptoms such as both sides of the chest distending pain, upper right abdomen discomforts.Through Drug therapy of the present invention after 4 months, 5 examples of fully recovering (50%), produce effects 3 examples (30%), effective 2 examples (20%).
(2) 10 routine women's nipple discharge patient clinical practices observation of the present invention is shown that the present invention has obvious curative effects to women's nipple discharge.The visible a large amount of plasma cells of laboratory examination discharge, lymphocyte before the treatment, the enlargement of homonymy axillary gland, matter be soft, tenderness, red, swollen, hot, the accompanying infection bitterly in indivedual lump parts are arranged.Through Drug therapy of the present invention after 20 days, 6 examples of fully recovering (60%), produce effects 3 examples (30%), invalid 1 example (10%).
(3) 15 example insomnia disease patient's clinical practices observation of the present invention is shown that the present invention has obvious curative effects to the insomnia disease.Patient's difficulty falling asleep before the treatment, dreaming often and waking easily, symptoms such as, headache depressed with lethargy, hypomnesis also have complication such as hypertension, coronary heart disease individually.After 60 days, spiritual antisecosis is quick on the draw through Drug therapy of the present invention, and various symptoms disappear substantially.9 examples of wherein fully recovering (60%), produce effects 3 examples (20%), effective 3 examples (20%).
(4) clinical observation to 15 routine gastrointestinal dysfunction disease patients shows that the present invention has obvious curative effects to the gastrointestinal dysfunction disease.Suffer from abdominal pain discomfort, borborygmus, abdominal distention of patient before the treatment is individually with symptoms such as nervous vomiting, diarrhoea, anxiety, amenorrheas.After 40 days, the mental status is good through Drug therapy of the present invention, and various symptoms disappear substantially.9 examples of wherein fully recovering (60%), produce effects 3 examples (20%), effective 1 example (6.7%), invalid 2 examples (13.3%).
The specific embodiment
Embodiment 1, adjust the Chinese medicine composition of human-body viscera function, get following parts by weight:
210 parts of Rhizoma Polygoni Cuspidati, 84 parts of Fructus Toosendans of stir-fry, 70 parts of Fructus Schisandrae Chinensis, 210 parts of Radix Scrophulariaes, 140 parts of Radix Salviae Miltiorrhizaes, 70 parts of Ramulus Cinnamomi, 70 parts in Semen Persicae, 63 parts of Radix Scutellariaes, 70 parts of Radix Et Rhizoma Rhei, 84 parts of Semen Arecaes, 105 parts of Rhizoma Bolbostematiss, 84 parts of Cortex Moutans, 35 parts on Flos Carthami, 70 parts of Carapax et Plastrum Testudiniss, 70 parts of Scorpios, 70 parts in Radix Glycyrrhizae, 70 parts of Carapax Trionycis, 70 parts in Poria, 140 parts of Concha Ostreae, 140 parts of Herba Hedyotidis Diffusaes, 70 parts of Radix Bupleuri, 21 parts of Rhizoma Coptidis, 70 parts of Fructus Aurantiis, clean and remove impurity, making pellets by mixing medical powder with honey after high-temperature sterilization.
In embodiment 2, the present embodiment, the raw material of Chinese medicine parts by weight are:
230 parts of Rhizoma Polygoni Cuspidati, 94 parts of Fructus Toosendans of stir-fry, 80 parts of Fructus Schisandrae Chinensis, 240 parts of Radix Scrophulariaes, 160 parts of Radix Salviae Miltiorrhizaes, 80 parts of Ramulus Cinnamomi, 80 parts in Semen Persicae, 73 parts of Radix Scutellariaes, 80 parts of Radix Et Rhizoma Rhei, 94 parts of Semen Arecaes, 125 parts of Rhizoma Bolbostematiss, 94 parts of Cortex Moutans, 40 parts on Flos Carthami, 80 parts of Carapax et Plastrum Testudiniss, 80 parts of Scorpios, 80 parts in Radix Glycyrrhizae, 80 parts of Carapax Trionycis, 80 parts in Poria, 160 parts of Concha Ostreae, 160 parts of Herba Hedyotidis Diffusaes, 80 parts of Radix Bupleuri, 24 parts of Rhizoma Coptidis, 80 parts of Fructus Aurantiis. other are with embodiment 1.
Embodiment 3, adjust the Chinese medicine composition of human-body viscera function, get following parts by weight:
270 parts of Rhizoma Polygoni Cuspidati, 108 parts of Fructus Toosendans of stir-fry, 90 parts of Fructus Schisandrae Chinensis, 270 parts of Radix Scrophulariaes, 180 parts of Radix Salviae Miltiorrhizaes, 90 parts of Ramulus Cinnamomi, 90 parts in Semen Persicae, 81 parts of Radix Scutellariaes, 90 parts of Radix Et Rhizoma Rhei, 108 parts of Semen Arecaes, 135 parts of Rhizoma Bolbostematiss, 108 parts of Cortex Moutans, 45 parts on Flos Carthami, 90 parts of Carapax et Plastrum Testudiniss, 90 parts of Scorpios, 90 parts in Radix Glycyrrhizae, 90 parts of Carapax Trionycis, 90 parts in Poria, 180 parts of Concha Ostreae, 180 parts of Herba Hedyotidis Diffusaes, 90 parts of Radix Bupleuri, 27 parts of Rhizoma Coptidis, 90 parts of Fructus Aurantiis, clean and remove impurity, dry post-treatment becomes fine powder, sterilization packaging.Through ripening, sterilization incapsulates, and makes capsule preparations.
Claims (4)
1. a Chinese medicine composition of adjusting human-body viscera function is characterized in that, is formed by following parts by weight of traditional Chinese medicines preparation of raw material:
Rhizoma Polygoni Cuspidati 210-270 part, fry Fructus Toosendan 84-108 part, Fructus Schisandrae Chinensis 70-90 part, Radix Scrophulariae 210-270 part, Radix Salviae Miltiorrhizae 140-180 part, Ramulus Cinnamomi 70-90 part, Semen Persicae 70-90 part, Radix Scutellariae 63-81 part, Radix Et Rhizoma Rhei 70-90, Semen Arecae 84-108 part, Rhizoma Bolbostematis 105-135 part, Cortex Moutan 84-108 part, Flos Carthami 35-45 part, Carapax et Plastrum Testudinis 70-90 part, Scorpio 70-90 part, Radix Glycyrrhizae 70-90 part, Carapax Trionycis 70-90 part, Poria 70-90 part, Concha Ostreae 140-180 part, Herba Hedyotidis Diffusae 140-180 part, Radix Bupleuri 70-90 part, Rhizoma Coptidis 21-27 part, Fructus Aurantii 70-90 part.
2. Chinese medicine composition as claimed in claim 1, it is characterized in that the raw material of Chinese medicine parts by weight are: 270 parts of Rhizoma Polygoni Cuspidati, 108 parts of Fructus Toosendans of stir-fry, 90 parts of Fructus Schisandrae Chinensis, 270 parts of Radix Scrophulariaes, 180 parts of Radix Salviae Miltiorrhizaes, 90 parts of Ramulus Cinnamomi, 90 parts in Semen Persicae, 81 parts of Radix Scutellariaes, 90 parts of Radix Et Rhizoma Rhei, 108 parts of Semen Arecaes, 135 parts of Rhizoma Bolbostematiss, 108 parts of Cortex Moutans, 45 parts on Flos Carthami, 90 parts of Carapax et Plastrum Testudiniss, 90 parts of Scorpios, 90 parts in Radix Glycyrrhizae, 90 parts of Carapax Trionycis, 90 parts in Poria, 180 parts of Concha Ostreae, 180 parts of Herba Hedyotidis Diffusaes, 90 parts of Radix Bupleuri, 27 parts of Rhizoma Coptidis, 90 parts of Fructus Aurantiis.
3. Chinese medicine composition as claimed in claim 1 or 2 is characterized in that, also contains to be prepared into the required excipient of common drug preparation.
4. Chinese medicine composition as claimed in claim 3 is characterized in that, it is any pharmaceutics dosage form.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200510107272A CN1981837B (en) | 2005-12-14 | 2005-12-14 | Chinese-medicinal composition for adjusting human-body viscera function |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200510107272A CN1981837B (en) | 2005-12-14 | 2005-12-14 | Chinese-medicinal composition for adjusting human-body viscera function |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1981837A CN1981837A (en) | 2007-06-20 |
| CN1981837B true CN1981837B (en) | 2010-05-05 |
Family
ID=38164868
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200510107272A Active CN1981837B (en) | 2005-12-14 | 2005-12-14 | Chinese-medicinal composition for adjusting human-body viscera function |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1981837B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104398877A (en) * | 2014-11-10 | 2015-03-11 | 青岛祥翔生物医药科技有限公司 | Traditional Chinese medicine for treating stomach and intestine diseases caused by dry intestines and deficient body fluid |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1279090A (en) * | 1999-06-25 | 2001-01-10 | 刘永香 | Powdered medicine for conditioning viscera and whole body |
| CN1444953A (en) * | 2002-03-14 | 2003-10-01 | 钟凯 | Health protection wine for improvement of inferior health |
-
2005
- 2005-12-14 CN CN200510107272A patent/CN1981837B/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1279090A (en) * | 1999-06-25 | 2001-01-10 | 刘永香 | Powdered medicine for conditioning viscera and whole body |
| CN1444953A (en) * | 2002-03-14 | 2003-10-01 | 钟凯 | Health protection wine for improvement of inferior health |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1981837A (en) | 2007-06-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101711850B (en) | Traditional Chinese medicine composition for treating symptoms of myocardial ischemia, palpitation and severe palpitation and preparation method | |
| CN103463568B (en) | Traditional Chinese medicine for treating coronary heart disease | |
| CN102526474B (en) | Chinese medicine composition for treating neurasthenia | |
| CN1475229A (en) | Antifatigue compound Chinese medicine prescription and its preparation method | |
| CN101095768B (en) | Chinese traditional medicine capsule for treating primary hypertension for persons in middle and old age | |
| CN102028842A (en) | Medicament for treating dysmenorrhea and preparation method thereof | |
| CN101745047A (en) | Chinese medicinal composition for treating gout disease and preparation method thereof | |
| CN103919966B (en) | A kind of medicine treating acne | |
| CN103599455B (en) | Traditional Chinese medicine capsule for removing freckle | |
| CN102755515B (en) | Traditional Chinese medicine decoction for treating hyperplasia of mammary glands | |
| CN1981837B (en) | Chinese-medicinal composition for adjusting human-body viscera function | |
| CN103705846A (en) | Traditional Chinese medicine preparation for treating ovarian cyst | |
| CN103495108B (en) | Medicine for treating chronic hypotension and preparation method for medicine | |
| CN102293946A (en) | Chinese medicinal composition for treating vertigo | |
| CN100459990C (en) | Medicine for treating coronary heart disease and preparation method thereof | |
| CN104547642A (en) | Tradtional Chinese medicine composition for treating female fibromyalgia syndromes | |
| CN103599185B (en) | A kind of Chinese medicine composition being used for the treatment of headache | |
| CN105832885A (en) | Traditional Chinese medicine composition for treating insomnia | |
| CN105194526A (en) | Traditional Chinese medicine for treating hepatic calculi | |
| CN1211116C (en) | Medicine for treating sympthetic nerve disorder | |
| CN1201802C (en) | Coronary heart disease treating Chinese herbal medicine capsule | |
| CN105412561A (en) | Medicine for treating anhypnia | |
| CN105169106A (en) | Traditional Chinese medicinal preparation for treating hyperplasia of mammary glands | |
| CN104306943A (en) | Traditional Chinese medicine combination for curing hyperlipidemia | |
| CN104042908A (en) | Traditional Chinese medicine composition for treating female climacteric syndrome |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |